Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fulgent Genetics, Inc. - Common Stock (NQ:FLGT)

22.02 -0.06 (-0.27%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 273,540
Open 22.07
Bid (Size) 21.81 (100)
Ask (Size) 22.24 (100)
Prev. Close 22.08
Today's Range 21.69 - 22.25
52wk Range 13.46 - 31.04
Shares Outstanding 29,926,846
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Think Outside the Box With These 3 Companies That Make Unusual Business Models Work ↗
Fulgent Genetics, Joby Aviation, and Veritone pursue unconventional business models in genomics, eVTOL aircraft, and AI media, backed by notable financial and operational milestones. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Fulgent Genetics (FLGT) Q2 2026 Earnings Call Transcript ↗
Billing delays pressured margins, though acquisitions drove anatomic pathology growth. 
Via The Motley Fool
Topics Earnings

Performance

YTD
-14.0%
-14.0%
1 Month
+13.7%
+13.7%
3 Month
+7.3%
+7.3%
6 Month
+38.5%
+38.5%
1 Year
-1.3%
-1.3%

More News

Read More
Fulgent Genetics (NASDAQ:FLGT) Plunges 10.6% After Q2 Miss and Guidance Cut ↗
Via Chartmill
News headline image
Fulgent Genetics Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Artificial Intelligence Earnings
Fulgent Genetics (NASDAQ:FLGT) Shares Dip Premarket After Q1 Earnings Miss Despite Revenue Beat ↗
Via Chartmill
Topics Earnings
News headline image
Fulgent Reports Second Quarter 2026 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Presents Updated FID-007 Data at ASCO 2026
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
News headline image
Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual Meeting
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
News headline image
Fulgent (FLGT) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Fulgent Reports First Quarter 2026 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Selected to Present Rapid Oral Abstract Within the Head and Neck Cancer Track Session at the 2026 ASCO Annual Meeting
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
News headline image
Fulgent to Announce First Quarter 2026 Financial Results on Friday, May 1, 2026
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
FULGENT INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
FLGT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Fulgent Genetics Inc.
From Kirby McInerney LLP
Via Business Wire
News headline image
FLGT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Fulgent Genetics Inc.
From Kirby McInerney LLP
Via GlobeNewswire
News headline image
FLGT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
From Kirby McInerney LLP
Via GlobeNewswire
News headline image
FULGENT GENETICS INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
From Kirby McInerney LLP
Via Business Wire
News headline image
Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
News headline image
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
From Pomerantz LLP
Via GlobeNewswire

Frequently Asked Questions

Is Fulgent Genetics, Inc. - Common Stock publicly traded?
Yes, Fulgent Genetics, Inc. - Common Stock is publicly traded.
What exchange does Fulgent Genetics, Inc. - Common Stock trade on?
Fulgent Genetics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Fulgent Genetics, Inc. - Common Stock?
The ticker symbol for Fulgent Genetics, Inc. - Common Stock is FLGT on the Nasdaq Stock Market
What is the current price of Fulgent Genetics, Inc. - Common Stock?
The current price of Fulgent Genetics, Inc. - Common Stock is 22.02
When was Fulgent Genetics, Inc. - Common Stock last traded?
The last trade of Fulgent Genetics, Inc. - Common Stock was at 09/30/26 04:00 PM ET
What is the market capitalization of Fulgent Genetics, Inc. - Common Stock?
The market capitalization of Fulgent Genetics, Inc. - Common Stock is 658.99M
How many shares of Fulgent Genetics, Inc. - Common Stock are outstanding?
Fulgent Genetics, Inc. - Common Stock has 659M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.